Results in countries distributing Ivermectin
Africa
Deaths are low in the tropical areas of central African Continent where ivermectin is distributed.
On the other hand, in South Africa, where the infection has not been distributed, the spread of the infection caused unique mutant strains and increased the mortality rate, which is noteworthy as a correlation between the distribution area of ivermectin and its effect.
Blue : Use of Ivermectin
Yellow : No use of Ivermectin
Mexico
🇲🇽 COVID-19 in Mexico
— J Chamie (@jjchamie) July 1, 2021
Mexico had the lowest death count since the beginning of 2020. Lowest than before COVID
What did they do different?
Test and treat strategy
Treatment: Ivermectin + Aspirin + Paracetamol
Affordable, available and effective! pic.twitter.com/9DXVzfmevx
India
Since the start of ivermectin administration in May, the number of Covid19 cases per day has plummeted from 25,000, and in June the number of Covid19 cases is settled.
Dr Frieden a former CDC director is omitting all the published studies showing ivermectin as an effective antiviral
— J Chamie (@jjchamie) August 28, 2021
How unscientific to say "it doesn’t work for Covid" without evidence and when the NIH is conducting a clinical trial on it?
Delta can be squashed, look at Delhi https://t.co/SBXCQJMoj4 pic.twitter.com/FOjJaTMRAq
The Role of IVERMECTIN in the Monumental decline of COVID19 Cases in INDIA
1. Regions who used Ivermectin showed the ff:
a. 87.42 % average significant decrease of COVID19 cases
b. 65.9 % average decrease of COVID19 deaths
2. Region who banned Ivermectin:
a. 21.26% decrease of COVID19 cases
b. Death cases are still peaking
Indonesia
Mortality comparison between countries distributing ivermectin and countries not distributing ivermectin
Orginal Article : Global Trends in Ivermectin and COVID19 Infection-5 (Japanese article)
Institut Pasteur Preclinical Study: Ivermectin a Powerful Immunomodulatory Drug Targeting SARS-CoV-2
France's Pastor Institute, the world's leading infectious disease researcher, confirmed in a preclinical hamster study that ivermectin dramatically reduces damage to COVID19-infected lung tissue. Announced the possibility of improving the condition of infected patients.
The National Institutes of Health NIH has finally begun clinical trials of ivermectin. A randomized clinical trial of up to 15,000 people nationwide. In addition to ivermectin, therapeutic agents include fluvoxamine and fluticasone.
この記事が気に入ったらサポートをしてみませんか？